PNV

4.74%

$2.43 polynovo limited

Writing a lot and hypothesizing doesn't make any of what you say...

First 53 Last

Share
Profile

Follow
BPAA

4,225 Posts.

787

05/05/23

11:59

Post #: 67624800
Share

Originally posted by Hapman: ↑

Then you’ll probably be missing quite a few millions for not understanding your investment in pharmaceutical/medical shares.
Why is the SP being so heavily punished? Simple fact is growth hasn’t met market expectations. Why is this important is the simple fact that BTM/MTX only enjoy a very limited patented window. PNV needs to grow and establish its branding and product as fast as possible. Every quarter/month that it does not achieve such aggressive growth means we are closer and closer to when cheap Chinese/Indian generics will enter and/or large pharmaceuticals will enter with their massive deep pockets, large marketing and sales force and channels to disrupt a minnow like PNV. Essentially, the margin that you guys chirp about will shrink.
So unless PNV can quickly establishes itself as market leader, build up a large cash kitty (patent period) to be able to defend its market share.
sorry to burst your dreams but this is a tough tough market to be in and you either become the big fish or you get swallowed whole (Take over) or kicked out (lose market share and leave).
I believe my growth target is valid is more than fair. 60+%coming from existing staff (18mths+ service and based on Ed comment that 4 customer per sales to be driven up to 10+ and cross department reach within same hospital) and 20-50% from new staff added (6-18 mths service and gave them some discount based on some of the new hires might be only 6 mths into their jobs).
To simply look at the 50% growth and be satisfied is ignoring that PNV have had lots more foot solders on the ground to aid our course and organic sales growth from existing soldiers. No offence to kick’s model but maybe it needs to be updated to reflect that the company is a lot larger and it’s target needs to reflect this fact.

Expand

Writing a lot and hypothesizing doesn't make any of what you say correct. It probably feels good but its so far off anything logical

There is nothing to support what you're saying apart from your opinion

PNV Price at posting: $1.50 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

There are more pages in this discussion • 35 more messages in this thread...

First 53 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.43		Change 0.110(4.74%)		Mkt cap ! $1.677B

Open	High	Low	Value	Volume
$2.39	$2.45	$2.38	$2.896M	1.198M

Buyers (Bids)

No.	Vol.	Price($)
1	3000	$2.41

Sellers (Offers)

Price($)	Vol.	No.
$2.43	9997	4

View Market Depth

No.	Vol.	Price($)
1	3000	2.410
1	1000	2.400
2	8896	2.390
2	4656	2.380
1	2656	2.370

Price($)	Vol.	No.
2.430	9997	4
2.440	30000	1
2.450	16310	3
2.460	2656	1
2.470	22772	5

Last trade - 16.10pm 09/08/2024 (20 minute delay)

PNV (ASX) Chart

Writing a lot and hypothesizing doesn't make any of what you say...

True North increases silver metal at QLD's Vero deposit by 20%

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Writing a lot and hypothesizing doesn't make any of what you say...

Top Stories

True North increases silver metal at QLD's Vero deposit by 20%

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News